Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 14;20(42):15756-62.
doi: 10.3748/wjg.v20.i42.15756.

Covert hepatic encephalopathy: agreement and predictive validity of different indices

Sara Montagnese  1 , Esmeralda Balistreri  1 , Sami Schiff  1 , Michele De Rui  1 , Paolo Angeli  1 , Giacomo Zanus  1 , Umberto Cillo  1 , Giancarlo Bombonato  1 , Massimo Bolognesi  1 , David Sacerdoti  1 , Angelo Gatta  1 , Carlo Merkel  1 , Piero Amodio  1
Affiliations

Covert hepatic encephalopathy: agreement and predictive validity of different indices

Sara Montagnese et al. World J Gastroenterol. .

Abstract

Aim: To investigate the agreement and prognostic value of different measures of covert hepatic encephalopathy (CHE).

Methods: One-hundred-and-thirty-two cirrhotic outpatients underwent electroencephalography (EEG), paper-and-pencil psychometry (PHES) and critical flicker frequency, scored on the original/modified (CFFo/CFFm) thresholds. Eighty-four patients underwent Doppler-ultrasound to diagnose/exclude portal-systemic shunt. Seventy-nine were followed-up for 11 ± 7 mo in relation to the occurrence of hepatic encephalopathy (HE)-related hospitalisations.

Results: On the day of study, 36% had grade I HE, 42% abnormal EEG, 33% abnormal PHES and 31/21% abnormal CFFo/CFFm. Significant associations were observed between combinations of test abnormalities; however, agreement was poor (Cohen's κ < 0.4). The prevalence of EEG, PHES and CFFo/CFFm abnormalities was significantly higher in patients with grade I overt HE. The prevalence of EEG and CFFm abnormalities was higher in patients with shunt. The prevalence of EEG abnormalities was significantly higher in patients with a history of HE. During follow-up, 10 patients died, 10 were transplanted and 29 had HE-related hospitalisations. Grade I HE (P = 0.004), abnormal EEG (P = 0.008) and abnormal PHES (P = 0.04) at baseline all predicted the subsequent occurrence of HE; CFF did not.

Conclusion: CHE diagnosis probably requires a combination of clinical, neurophysiological and neuropsychological indices.

Keywords: Ammonia; Electroencephalography; Hepatic encephalopathy; Liver cirrhosis; Psychometry.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cumulative hepatic encephalopathy-free survival. Cumulative hepatic encephalopathy (HE)-free survival over the follow-up period in relation to the combination of electroencephalographic (EEG) and clinical abnormalities (panel A, χ2 = 8.2, P = 0.041) and the combination of psychometric hepatic encephalopathy score (PHES) and clinical abnormalities (panel B, χ2 = 7.8, P = 0.050) at baseline.
Figure 2
Figure 2
Model for end-stage liver disease scores in patients. Model for end-stage liver disease scores (MELD) in patients grouped based on the combination of electroencephalographic (EEG) and clinical abnormalities (panel A) and the combination of psychometric hepatic encephalopathy score (PHES) and clinical abnormalities (panel B). aP < 0.05, bP < 0.01 vs post-hoc comparisons.
See this image and copyright information in PMC

References

    1. Kircheis G, Fleig WE, Görtelmeyer R, Grafe S, Häussinger D. Assessment of low-grade hepatic encephalopathy: a critical analysis. J Hepatol. 2007;47:642–650. - PubMed
    1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716–721. - PubMed
    1. Bajaj JS, Cordoba J, Mullen KD, Amodio P, Shawcross DL, Butterworth RF, Morgan MY. Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther. 2011;33:739–747. - PMC - PubMed
    1. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649. - PubMed
    1. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D’Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470. - PubMed

Publication types

MeSH terms